Thomas Teisseyre Sells 24,188 Shares of Hyperfine (NASDAQ:HYPR) Stock

Hyperfine, Inc. (NASDAQ:HYPR) COO Thomas Teisseyre sold 24,188 shares of the stock in a transaction on Monday, March 23rd. The stock was sold at an average price of $1.21, for a total transaction of $29,267.48. Following the transaction, the chief operating officer owned 354,648 shares of the company’s stock, valued at $429,124.08. The trade was a 6.38% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Hyperfine Trading Down 4.3%

Shares of HYPR stock opened at $1.12 on Friday. Hyperfine, Inc. has a 1 year low of $0.53 and a 1 year high of $2.22. The firm’s fifty day moving average price is $1.16 and its two-hundred day moving average price is $1.20. The firm has a market capitalization of $108.83 million, a P/E ratio of -2.55 and a beta of 1.09.

Hyperfine (NASDAQ:HYPR) last issued its quarterly earnings results on Wednesday, March 18th. The company reported ($0.06) EPS for the quarter, topping the consensus estimate of ($0.08) by $0.02. The firm had revenue of $5.29 million for the quarter, compared to analysts’ expectations of $5.30 million. Hyperfine had a negative net margin of 262.29% and a negative return on equity of 95.09%. As a group, equities research analysts forecast that Hyperfine, Inc. will post -0.57 EPS for the current fiscal year.

Institutional Investors Weigh In On Hyperfine

Several hedge funds have recently bought and sold shares of the company. EP Wealth Advisors LLC bought a new position in Hyperfine during the fourth quarter worth about $34,000. Sanctuary Advisors LLC raised its stake in Hyperfine by 130.9% in the fourth quarter. Sanctuary Advisors LLC now owns 39,938 shares of the company’s stock valued at $39,000 after buying an additional 22,638 shares during the period. Tortoise Investment Management LLC bought a new stake in Hyperfine in the third quarter valued at approximately $65,000. Kathmere Capital Management LLC acquired a new stake in shares of Hyperfine in the fourth quarter valued at approximately $51,000. Finally, Millennium Management LLC bought a new position in shares of Hyperfine during the 4th quarter worth approximately $55,000. 15.03% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research analysts recently commented on HYPR shares. Lake Street Capital increased their price target on Hyperfine from $2.00 to $2.50 and gave the company a “buy” rating in a research report on Thursday, March 19th. Zacks Research upgraded Hyperfine to a “hold” rating in a research note on Thursday, March 19th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Hyperfine in a report on Thursday, January 22nd. Two equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Hyperfine currently has a consensus rating of “Hold” and a consensus price target of $1.45.

About Hyperfine

Hyperfine, Inc (NASDAQ: HYPR) is a medical technology company focused on expanding access to advanced neuroimaging through its portable magnetic resonance imaging (MRI) system. The company’s flagship product, Swoop®, is designed to enable bedside MRI scanning in a wide range of clinical environments, including emergency departments, intensive care units and outpatient clinics. By leveraging a compact, high-performance permanent magnet and a custom-designed gradient system, Hyperfine aims to reduce the logistical and financial barriers associated with traditional, large-scale MRI installations.

The Swoop system features a lightweight, wheeled design that can be maneuvered directly to a patient’s bedside, allowing clinicians to conduct diagnostic imaging without the need to transport critically ill or immobile patients.